Valproic acid capsule delayed release how supplied storage and handling

Valproic acid
DEPAKENE® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
STAVZOR® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Valproic acid
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

How Supplied/Storage And Handling

Stavzor (valproic acid) delayed-release capsules are supplied as:

• 125-mg orange-colored, oval-shaped capsules with NVN in black print:

Bottles of 100 (NDC 68968-3125-1)

• 250-mg orange-colored, oval-shaped capsules with NVN1 in black print:

Bottles of 100 (NDC 68968-3250-1)

• 500-mg orange-colored, oval-shaped capsules with NVN2 in black print:

Bottles of 100 (NDC 68968-3500-1)

References

Adapted from the FDA Package Insert.